Cytokine Dysregulation in Aged Horses and Horses with Pituitary Pars Intermedia Dysfunction

Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs i...

Full description

Saved in:
Bibliographic Details
Published inJournal of veterinary internal medicine Vol. 22; no. 2; pp. 436 - 442
Main Authors McFarlane, D, Holbrook, T.C
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.03.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones.
AbstractList Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-a plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-a response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-g as well as PBMC TNF-a release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones. Submitted June 27, 2007; Revised October 5, 2007; Accepted November 19, 2007.
Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones.
Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Aged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group). Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-alpha plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-alpha response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Aged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-gamma as well as PBMC TNF-alpha release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls. Aged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones.
BACKGROUNDEquine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID.HYPOTHESISHorses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses.ANIMALSAged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group).METHODSTotal leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-alpha plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-alpha response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA.RESULTSAged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-gamma as well as PBMC TNF-alpha release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls.CONCLUSIONS AND CLINICAL IMPORTANCEAged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones.
Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones.
Author Holbrook, T.C.
McFarlane, D.
Author_xml – sequence: 1
  fullname: McFarlane, D
– sequence: 2
  fullname: Holbrook, T.C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18371032$$D View this record in MEDLINE/PubMed
BookMark eNqNkk9v0zAYxi20iXUbX4HlBKcU_4ntRJymAm3ZxiaxwYHDKye2i7s0GXaitd8eR6m6G8IXv7J-z2P5eXyKjpq2MQhdEDwlcX1YT0nBipQIKaYU43yKcZy2r9DkcH6EJjgvSCpEhk_QaQhrjCnnXL5GJyRnkmBGJ-jXbNe1j64xyadd8GbV16pzbZO4JrlcGZ0sWh9MSFRzGJ9d9zu5c13vOuV3yZ3yIVk2nfEbo50abGzfVIPJOTq2qg7mzX4_Qw9fPt_PFun17Xw5u7xOK46FSKnOi0wSK0rFRUUYVcYWXJe5LVhmGLa6MKUg0pa5pJwqYbW2pZTUaqvLkrEz9H70ffLtn96EDjYuVKauVWPaPkCBKWOckiyS7_5JSpxxwngeQTmClW9DzMXCk3eb-F4gGIYGYA1D0jAkDUMDMDQA26h8u7-iL2MiL7p95BH4OALPrja7__WFrz-WN1JEdTqqXejM9qBW_hGEZJLDz29z4Iurq_n9DYVZ5C9G3qoW1Mq7AA_fKSYsWuc8fhD2F-UFr4A
CitedBy_id crossref_primary_10_1016_j_tvjl_2011_03_021
crossref_primary_10_1111_j_1751_0813_2010_00637_x
crossref_primary_10_1016_j_vetimm_2010_06_018
crossref_primary_10_1016_j_domaniend_2014_07_003
crossref_primary_10_2460_javma_243_12_1762
crossref_primary_10_1007_s12015_015_9638_0
crossref_primary_10_1016_j_domaniend_2020_106531
crossref_primary_10_1016_j_jevs_2010_07_015
crossref_primary_10_1111_evj_12045
crossref_primary_10_2460_ajvr_75_7_658
crossref_primary_10_1186_s12917_016_0742_4
crossref_primary_10_1111_j_1939_1676_2012_01022_x
crossref_primary_10_3727_215517912X647217
crossref_primary_10_1016_j_vetimm_2014_02_001
crossref_primary_10_1111_eve_12749
crossref_primary_10_1111_j_2042_3306_2010_00085_x
crossref_primary_10_1111_jvim_15302
crossref_primary_10_1016_j_jevs_2013_01_006
crossref_primary_10_1186_s12917_019_2144_x
crossref_primary_10_1371_journal_pone_0254139
crossref_primary_10_1186_s12979_022_00325_5
crossref_primary_10_3389_fragi_2021_708918
crossref_primary_10_1089_scd_2013_0537
crossref_primary_10_1111_eve_12237
crossref_primary_10_1016_j_dci_2012_11_007
crossref_primary_10_1016_j_vetimm_2022_110459
crossref_primary_10_2460_javma_241_2_241
crossref_primary_10_1016_j_vetimm_2020_110013
crossref_primary_10_2460_javma_238_10_1305
crossref_primary_10_1016_j_cveq_2016_04_009
crossref_primary_10_1111_j_2042_3306_2010_00092_x
crossref_primary_10_1016_j_cveq_2019_03_005
crossref_primary_10_1016_j_domaniend_2020_106476
crossref_primary_10_1016_j_jevs_2023_104879
crossref_primary_10_1016_j_cveq_2010_12_007
crossref_primary_10_1016_j_jevs_2021_103824
crossref_primary_10_3390_vetsci9100556
crossref_primary_10_3390_ani12060744
crossref_primary_10_1111_j_2042_3292_2011_00327_x
crossref_primary_10_1016_j_tvjl_2013_07_020
crossref_primary_10_1016_j_jevs_2011_03_056
crossref_primary_10_2527_jas_2015_9634
crossref_primary_10_3389_fvets_2024_1414426
crossref_primary_10_1016_j_prevetmed_2011_06_002
crossref_primary_10_1111_j_2042_3306_2010_00256_x
crossref_primary_10_1111_j_2042_3306_2012_00600_x
crossref_primary_10_1111_eve_13593
crossref_primary_10_1016_j_jevs_2009_01_004
crossref_primary_10_1002_jor_20933
crossref_primary_10_1111_vop_12817
crossref_primary_10_1016_j_jveb_2015_08_007
crossref_primary_10_3390_cells10051138
crossref_primary_10_1177_0300985815608674
crossref_primary_10_1016_j_vetimm_2015_04_006
Cites_doi 10.1016/j.exger.2006.09.005
10.1210/me.12.8.1133
10.1016/S0047-6374(97)00153-X
10.1016/j.intimp.2004.05.006
10.1002/path.2104
10.1159/000126999
10.1212/WNL.38.8.1285
10.1097/01.jnen.0000202887.22082.63
10.1093/gerona/60.2.195
10.1002/glia.20015
10.1111/j.2042-3292.1992.tb01595.x
10.1111/j.1365-2826.2005.01277.x
10.1016/j.jneuroim.2005.01.008
10.2460/ajvr.2004.65.1701
10.1515/CCLM.2003.136
10.1016/S0531-5565(01)00189-9
10.2460/javma.2003.223.99
10.1111/j.1939-1676.2002.tb02418.x
10.2460/ajvr.2004.65.1463
10.1016/0006-8993(95)01189-7
10.2746/042516402776250333
10.2527/jas.2006-673
ContentType Journal Article
Copyright Copyright © 2008 by the American College of Veterinary Internal Medicine
Copyright_xml – notice: Copyright © 2008 by the American College of Veterinary Internal Medicine
DBID FBQ
BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T5
7TK
H94
DOI 10.1111/j.1939-1676.2008.0076.x
DatabaseName AGRIS
Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Neurosciences Abstracts
Immunology Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Veterinary Medicine
EISSN 1939-1676
EndPage 442
ExternalDocumentID 10_1111_j_1939_1676_2008_0076_x
18371032
JVIM76
ark_67375_WNG_5HKKGTM2_C
US201300885089
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID .3N
.GA
.Y3
05W
0R~
10A
1OC
24P
29L
31~
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FE
8FH
8FI
8FJ
8UM
930
A03
AAHHS
AAONW
AAZKR
ABCQN
ABEML
ABPTK
ABUWG
ACBWZ
ACCFJ
ACSCC
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AENEX
AEQDE
AEUQT
AFBPY
AFKRA
AFRAH
AFZJQ
AHEFC
AHMBA
AI.
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVUZU
AVWKF
AZBYB
AZFZN
BAFTC
BAWUL
BCNDV
BDRZF
BENPR
BFHJK
BPHCQ
BVXVI
BY8
CAG
CCPQU
COF
CS3
D-E
D-F
DIK
DR2
DU5
EBS
ECGQY
EJD
ESX
EYRJQ
F00
F01
F04
FBQ
FEDTE
FYUFA
G-S
G.N
GODZA
GROUPED_DOAJ
H.T
H.X
HF~
HMCUK
HOLLA
HVGLF
HYE
HZ~
IAO
IHR
IX1
J0M
KQ8
LC2
LC3
LH4
LP6
LP7
LW6
M48
MK4
N04
N05
N9A
NF~
O9-
OK1
OVD
P2P
P2X
P4D
PIMPY
PQQKQ
PROAC
Q.N
Q11
R.K
ROL
RPM
RX1
SJN
SUPJJ
TEORI
UB1
UKHRP
VH1
W8V
W99
WIN
WQJ
WRC
XG1
~IA
~KM
~WT
AAHBH
ALIPV
ALUQN
BSCLL
ITC
OIG
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T5
7TK
H94
ID FETCH-LOGICAL-c5066-2d89471f6ba56c132aef95db8f934e30fd9eb617fb87252a6fddfb772fdfdbb33
IEDL.DBID M48
ISSN 0891-6640
IngestDate Fri Aug 16 10:21:02 EDT 2024
Fri Aug 16 10:38:19 EDT 2024
Thu Sep 26 18:08:06 EDT 2024
Sat Sep 28 07:55:05 EDT 2024
Sat Aug 24 00:54:10 EDT 2024
Wed Oct 30 10:05:27 EDT 2024
Mon Dec 18 05:21:16 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5066-2d89471f6ba56c132aef95db8f934e30fd9eb617fb87252a6fddfb772fdfdbb33
Notes ark:/67375/WNG-5HKKGTM2-C
istex:D23256C38759F635A51C6762523AA75CFF2439A2
ArticleID:JVIM76
Portions of this work were presented at the 25th American College of Veterinary Internal Medicine Forum, June 2007, Seattle, WA.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1939-1676.2008.0076.x
PMID 18371032
PQID 70451358
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_902335214
proquest_miscellaneous_70451358
crossref_primary_10_1111_j_1939_1676_2008_0076_x
pubmed_primary_18371032
wiley_primary_10_1111_j_1939_1676_2008_0076_x_JVIM76
istex_primary_ark_67375_WNG_5HKKGTM2_C
fao_agris_US201300885089
PublicationCentury 2000
PublicationDate March–April 2008
PublicationDateYYYYMMDD 2008-03-01
PublicationDate_xml – month: 03
  year: 2008
  text: March–April 2008
PublicationDecade 2000
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: United States
PublicationTitle Journal of veterinary internal medicine
PublicationTitleAlternate J Vet Intern Med
PublicationYear 2008
Publisher Blackwell Publishing Inc
Publisher_xml – name: Blackwell Publishing Inc
References Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 2005;162:43-50.
Van Der Kolk JH, Heinrichs M, Van Amerongen JD, et al. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am J Vet Res 2004;65:1701-1707.
Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003;39:889-909.
Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002;37:235-247.
Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinol 1982;110:1430-1441.
Leng S, Xue QL, Huang Y, et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci 2005;60:195-199.
Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199-209.
Van Der Kolk HH, Kalsbeek HC, Van Garderen E, et al. Equine pituitary neoplasia: A clinical report of 21 cases (1990-1992). Vet Rec 1993;133:594-597.
Bronstein DM, Perez-Otano I, Sun V, et al. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 1995;704:112-116.
Kurkowska-Jastrzebska I, Litwin T, Joniec I, et al. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. Int Immunopharmacol 2004;4:1307-1318.
Jerin A, Pozar-Lukanovic N, Sojar V, et al. Balance of pro- and anti-inflammatory cytokines in liver surgery. Clin Chem Lab Med 2003;41:899-903.
D'Acquisto F, Ianaro A. From willow bark to peptides: The ever widening spectrum of NF-kappaB inhibitors. Curr Opin Pharmacol 2006;6:387-392.
Millington WR, Dybdal NO, Dawson R Jr, et al. Equine Cushing's disease: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary. Endocrinol 1988;123:1598-1604.
McGeer PL, Itagaki S, Boyes BE, et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291.
Gao HM, Jiang J, Wilson B, et al. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J Neurochem 2002;81:1285-1297.
Barcia C, Sanchez BA, Fernandez-Villalba E, et al. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 2004;46:402-409.
Goudreau JL, Falls WM, Lookingland KJ, et al. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinol 1995;62:147-154.
Conde JR, Streit WJ. Microglia in the aging brain. J Neuropathol Exp Neurol 2006;65:199-203.
Vick MM, Adams AA, Murphy BA, et al. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci 2007;85:1144-1155.
Nagatsu T, Sawada M. Inflammatory process in Parkinson's disease: Role for cytokines. Curr Pharm Des 2005;11:999-1016.
McFarlane D, Donaldson MT, McDonnell SM, et al. Effects of season and sample handling on measurement of plasma alpha-melanocyte-stimulating hormone concentrations in horses and ponies. Am J Vet Res 2004;65:1463-1468.
Saiardi A, Borrelli E. Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol Endocrinol 1998;12:1133-1139.
Prior C, Knight RA, Herold M, et al. Pulmonary sarcoidosis: Patterns of cytokine release in vitro. Eur Respir J 1996;9:47-53.
McFarlane D, Dybdal N, Donaldson MT, et al. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol 2005;17:73-80.
Schott HC. Pituitary pars intermedia dysfunction: Equine Cushing's disease. Vet Clin North Am Equine Pract 2002;18:237-270.
Perkins GA, Lamb S, Erb HN, et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet J 2002;34:679-685.
Eylar EH, Lefranc CE, Yamamura Y, et al. HIV infection and aging: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+. BMC Immunol 2001;2:10.
Pawelec G. Immunity and ageing in man. Exp Gerontol 2006;41:1239-1242.
Donaldson MT, LaMonte BJ, Morresey P, et al. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease). J Vet Intern Med 2002;16:742-746.
Brosnahan MM, Paradis MR. Assessment of clinical characteristics, management practices, and activities of geriatric horses. J Am Vet Med Assoc 2003;223:99-103.
Hillyer MH, Taylor FRG, Mair TS, et al. Diagnosis of hyperadrenocorticism in the horse. Equine Vet Educ 1992;4:131-134.
Gruver A, Hudson L, Sempowski G. Immunosenescence of ageing. J Pathol 2007;211:144-156.
2004; 65
2002; 16
2002; 37
2002; 18
2002; 34
1988; 38
2004; 46
2004; 4
1988; 123
2006; 6
2003; 39
2002; 81
2005; 60
1995; 62
2007; 211
2006; 41
2005; 162
2001
2000
2006; 65
1995; 704
1982; 110
2001; 2
2007; 85
2003; 223
2005; 17
1998; 102
2003; 41
1998; 12
2005; 11
1996; 9
1992; 4
1993; 133
e_1_2_7_3_2
Rozen S (e_1_2_7_22_2) 2000
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
Prior C (e_1_2_7_30_2) 1996; 9
e_1_2_7_18_2
Van Der Kolk HH (e_1_2_7_32_2) 1993; 133
Orth DN (e_1_2_7_4_2) 1982; 110
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_13_2
e_1_2_7_11_2
e_1_2_7_10_2
Eylar EH (e_1_2_7_29_2) 2001; 2
Gao HM (e_1_2_7_17_2) 2002; 81
e_1_2_7_26_2
Dauer W (e_1_2_7_12_2) 2003; 39
e_1_2_7_27_2
e_1_2_7_28_2
Millington WR (e_1_2_7_5_2) 1988; 123
Schott HC. (e_1_2_7_31_2) 2002; 18
D'Acquisto F (e_1_2_7_35_2) 2006; 6
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_23_2
Nagatsu T (e_1_2_7_14_2) 2005; 11
e_1_2_7_21_2
e_1_2_7_33_2
e_1_2_7_20_2
e_1_2_7_34_2
References_xml – volume: 38
  start-page: 1285
  year: 1988
  end-page: 1291
  article-title: Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
  publication-title: Neurology
– volume: 46
  start-page: 402
  year: 2004
  end-page: 409
  article-title: Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
  publication-title: Glia
– volume: 16
  start-page: 742
  year: 2002
  end-page: 746
  article-title: Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)
  publication-title: J Vet Intern Med
– volume: 162
  start-page: 43
  year: 2005
  end-page: 50
  article-title: The immunomodulating neuropeptide alpha‐melanocyte‐stimulating hormone (alpha‐MSH) suppresses LPS‐stimulated TLR4 with IRAK‐M in macrophages
  publication-title: J Neuroimmunol
– volume: 60
  start-page: 195
  year: 2005
  end-page: 199
  article-title: Total and differential white blood cell counts and their associations with circulating interleukin‐6 levels in community‐dwelling older women
  publication-title: J Gerontol A Biol Sci Med Sci
– volume: 34
  start-page: 679
  year: 2002
  end-page: 685
  article-title: Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide
  publication-title: Equine Vet J
– volume: 65
  start-page: 1463
  year: 2004
  end-page: 1468
  article-title: Effects of season and sample handling on measurement of plasma alpha‐melanocyte‐stimulating hormone concentrations in horses and ponies
  publication-title: Am J Vet Res
– volume: 81
  start-page: 1285
  year: 2002
  end-page: 1297
  article-title: Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons
  publication-title: Relevance to Parkinson's disease
– volume: 2
  start-page: 10
  year: 2001
  article-title: HIV infection and aging
  publication-title: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+
– volume: 6
  start-page: 387
  year: 2006
  end-page: 392
  article-title: From willow bark to peptides
  publication-title: The ever widening spectrum of NF-kappaB inhibitors
– volume: 102
  start-page: 199
  year: 1998
  end-page: 209
  article-title: Altered cytokine production in the elderly
  publication-title: Mech Ageing Dev
– volume: 4
  start-page: 1307
  year: 2004
  end-page: 1318
  article-title: Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
  publication-title: Int Immunopharmacol
– volume: 11
  start-page: 999
  year: 2005
  end-page: 1016
  article-title: Inflammatory process in Parkinson's disease
  publication-title: Role for cytokines
– volume: 85
  start-page: 1144
  year: 2007
  end-page: 1155
  article-title: Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse
  publication-title: J Anim Sci
– volume: 18
  start-page: 237
  year: 2002
  end-page: 270
  article-title: Pituitary pars intermedia dysfunction
  publication-title: Equine Cushing's disease
– volume: 12
  start-page: 1133
  year: 1998
  end-page: 1139
  article-title: Absence of dopaminergic control on melanotrophs leads to Cushing's‐like syndrome in mice
  publication-title: Mol Endocrinol
– volume: 41
  start-page: 899
  year: 2003
  end-page: 903
  article-title: Balance of pro‐ and anti‐inflammatory cytokines in liver surgery
  publication-title: Clin Chem Lab Med
– volume: 65
  start-page: 199
  year: 2006
  end-page: 203
  article-title: Microglia in the aging brain
  publication-title: J Neuropathol Exp Neurol
– volume: 223
  start-page: 99
  year: 2003
  end-page: 103
  article-title: Assessment of clinical characteristics, management practices, and activities of geriatric horses
  publication-title: J Am Vet Med Assoc
– volume: 39
  start-page: 889
  year: 2003
  end-page: 909
  article-title: Parkinson's disease
  publication-title: Mechanisms and models
– volume: 37
  start-page: 235
  year: 2002
  end-page: 247
  article-title: Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly
  publication-title: Exp Gerontol
– volume: 41
  start-page: 1239
  year: 2006
  end-page: 1242
  article-title: Immunity and ageing in man
  publication-title: Exp Gerontol
– volume: 110
  start-page: 1430
  year: 1982
  end-page: 1441
  article-title: Equine Cushing's disease
  publication-title: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests
– start-page: 22
  year: 2001
  end-page: 24
– volume: 123
  start-page: 1598
  year: 1988
  end-page: 1604
  article-title: Equine Cushing's disease
  publication-title: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary
– volume: 17
  start-page: 73
  year: 2005
  end-page: 80
  article-title: Nitration and increased alpha‐synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction
  publication-title: J Neuroendocrinol
– volume: 62
  start-page: 147
  year: 1995
  end-page: 154
  article-title: Periventricular‐hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland
  publication-title: Neuroendocrinol
– volume: 4
  start-page: 131
  year: 1992
  end-page: 134
  article-title: Diagnosis of hyperadrenocorticism in the horse
  publication-title: Equine Vet Educ
– volume: 704
  start-page: 112
  year: 1995
  end-page: 116
  article-title: Glia‐dependent neurotoxicity and neuroprotection in mesencephalic cultures
  publication-title: Brain Res
– start-page: 365
  year: 2000
  end-page: 386
– volume: 65
  start-page: 1701
  year: 2004
  end-page: 1707
  article-title: Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma
  publication-title: Am J Vet Res
– volume: 133
  start-page: 594
  year: 1993
  end-page: 597
  article-title: Equine pituitary neoplasia
  publication-title: A clinical report of 21 cases (1990–1992)
– volume: 211
  start-page: 144
  year: 2007
  end-page: 156
  article-title: Immunosenescence of ageing
  publication-title: J Pathol
– volume: 9
  start-page: 47
  year: 1996
  end-page: 53
  article-title: Pulmonary sarcoidosis
  publication-title: Patterns of cytokine release in vitro
– ident: e_1_2_7_24_2
  doi: 10.1016/j.exger.2006.09.005
– volume: 9
  start-page: 47
  year: 1996
  ident: e_1_2_7_30_2
  article-title: Pulmonary sarcoidosis
  publication-title: Patterns of cytokine release in vitro
  contributor:
    fullname: Prior C
– ident: e_1_2_7_11_2
  doi: 10.1210/me.12.8.1133
– ident: e_1_2_7_25_2
  doi: 10.1016/S0047-6374(97)00153-X
– volume: 81
  start-page: 1285
  year: 2002
  ident: e_1_2_7_17_2
  article-title: Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons
  publication-title: Relevance to Parkinson's disease
  contributor:
    fullname: Gao HM
– volume: 110
  start-page: 1430
  year: 1982
  ident: e_1_2_7_4_2
  article-title: Equine Cushing's disease
  publication-title: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests
  contributor:
    fullname: Orth DN
– ident: e_1_2_7_18_2
  doi: 10.1016/j.intimp.2004.05.006
– ident: e_1_2_7_19_2
  doi: 10.1002/path.2104
– volume: 6
  start-page: 387
  year: 2006
  ident: e_1_2_7_35_2
  article-title: From willow bark to peptides
  publication-title: The ever widening spectrum of NF-kappaB inhibitors
  contributor:
    fullname: D'Acquisto F
– volume: 11
  start-page: 999
  year: 2005
  ident: e_1_2_7_14_2
  article-title: Inflammatory process in Parkinson's disease
  publication-title: Role for cytokines
  contributor:
    fullname: Nagatsu T
– ident: e_1_2_7_10_2
  doi: 10.1159/000126999
– volume: 123
  start-page: 1598
  year: 1988
  ident: e_1_2_7_5_2
  article-title: Equine Cushing's disease
  publication-title: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary
  contributor:
    fullname: Millington WR
– volume: 18
  start-page: 237
  year: 2002
  ident: e_1_2_7_31_2
  article-title: Pituitary pars intermedia dysfunction
  publication-title: Equine Cushing's disease
  contributor:
    fullname: Schott HC.
– ident: e_1_2_7_13_2
  doi: 10.1212/WNL.38.8.1285
– volume: 39
  start-page: 889
  year: 2003
  ident: e_1_2_7_12_2
  article-title: Parkinson's disease
  publication-title: Mechanisms and models
  contributor:
    fullname: Dauer W
– ident: e_1_2_7_20_2
  doi: 10.1097/01.jnen.0000202887.22082.63
– ident: e_1_2_7_28_2
  doi: 10.1093/gerona/60.2.195
– start-page: 365
  volume-title: Bioinformatics Methods and Protocols: Methods in Molecular Biology
  year: 2000
  ident: e_1_2_7_22_2
  contributor:
    fullname: Rozen S
– volume: 2
  start-page: 10
  year: 2001
  ident: e_1_2_7_29_2
  article-title: HIV infection and aging
  publication-title: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+
  contributor:
    fullname: Eylar EH
– ident: e_1_2_7_15_2
  doi: 10.1002/glia.20015
– ident: e_1_2_7_33_2
  doi: 10.1111/j.2042-3292.1992.tb01595.x
– volume: 133
  start-page: 594
  year: 1993
  ident: e_1_2_7_32_2
  article-title: Equine pituitary neoplasia
  publication-title: A clinical report of 21 cases (1990–1992)
  contributor:
    fullname: Van Der Kolk HH
– ident: e_1_2_7_9_2
  doi: 10.1111/j.1365-2826.2005.01277.x
– ident: e_1_2_7_34_2
  doi: 10.1016/j.jneuroim.2005.01.008
– ident: e_1_2_7_3_2
  doi: 10.2460/ajvr.2004.65.1701
– ident: e_1_2_7_26_2
  doi: 10.1515/CCLM.2003.136
– ident: e_1_2_7_27_2
  doi: 10.1016/S0531-5565(01)00189-9
– ident: e_1_2_7_2_2
  doi: 10.2460/javma.2003.223.99
– ident: e_1_2_7_6_2
  doi: 10.1111/j.1939-1676.2002.tb02418.x
– ident: e_1_2_7_21_2
  doi: 10.2460/ajvr.2004.65.1463
– ident: e_1_2_7_7_2
– ident: e_1_2_7_16_2
  doi: 10.1016/0006-8993(95)01189-7
– ident: e_1_2_7_8_2
  doi: 10.2746/042516402776250333
– ident: e_1_2_7_23_2
  doi: 10.2527/jas.2006-673
SSID ssj0025557
Score 2.173727
Snippet Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to...
Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of...
Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to...
BACKGROUNDEquine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to...
SourceID proquest
crossref
pubmed
wiley
istex
fao
SourceType Aggregation Database
Index Database
Publisher
StartPage 436
SubjectTerms age
Aging - physiology
Animals
Cushing syndrome
cytokines
Cytokines - genetics
Cytokines - metabolism
endocrine diseases
Equine Cushing's disease
Gene Expression Regulation
Geriatric
Horse Diseases - metabolism
Horses
Inflammation
Pituitary Diseases - metabolism
Pituitary Diseases - physiopathology
Pituitary Diseases - veterinary
Pituitary Gland - physiopathology
Pituitary Gland, Intermediate - metabolism
Pituitary Gland, Intermediate - physiopathology
RNA, Messenger - metabolism
Tumor Necrosis Factor-alpha - blood
Tumor Necrosis Factor-alpha - metabolism
SummonAdditionalLinks – databaseName: Wiley Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZteumltOkj7lOH0ptBfkiWjmHbZJuwYaHZNNCDkCxpWQJ2SbyQ_PvOyNptF1Iovelgj22NR_pm9OkTIR9RFI05CEDGg8zrthBIApC5q3xTM2laFwtuszMxXdQnl_wySQrhXphRH2JbcMPIiOM1BrixN7tBriqVF6IRG0oktABOPkL9GJTRL-v5NvfiPIl-qiIXomaJ6pVIPfcZ2pmoHgbTA3zFnr-9D4vuQts4Nx09JU8SqKSH41_wjDzw3T7Zv0CmS9xuS2dpBf05-TG5G_oraNLPd_DQZTq9i646erj0jk57JHVQ022bWKml89WwXg1oag6ZMI11xLjpBM3g3IhGXpDF0ZfzyTRPByzkLQeokZdOKpicgrCGixbyUuOD4s7KoKraVyw45S1AnGBlU_LSiOBcsIDHgwvO2qp6Sfa6vvMHhBpILfFsKo6CRlwy1bZVUyjJwNs2tCwjbNOb-ueoo6H_yD_AARodkE7FBAfo24wcQK9rs4TRTi--lbjGCmMiIEqVkU_RFVtT5voKGWoN19_PjjWfnp4en89KPcnIh42vNMQNLoaYzvfrG92gsE7FZUboX65QAGcAnhZ1Rl6NXv795pDWoxJhRuro9n_9JH1y8XXWiNf_d9sb8nhkqyAD7i3ZG67X_h1AosG-jz_7L-CJ_SM
  priority: 102
  providerName: Wiley-Blackwell
Title Cytokine Dysregulation in Aged Horses and Horses with Pituitary Pars Intermedia Dysfunction
URI https://api.istex.fr/ark:/67375/WNG-5HKKGTM2-C/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1939-1676.2008.0076.x
https://www.ncbi.nlm.nih.gov/pubmed/18371032
https://search.proquest.com/docview/70451358
https://search.proquest.com/docview/902335214
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED-x8cILgvGx8DH8gHgLShPbsR8QQoWtW9UJwTom8WA5cTyqoaR0qdT-99ylbrdJG-LF8kN0Se788Tvfz3cAbykpWuJwAibCq5iXPUkkABW7rMp5omzpugO30bEcjPnRmTi7ulkXFHh5q2tH9aTGs9_vF3-WH3HCf7jGytGZjnsyl2tyJPYQWN5PObrrxOfjm9ACQuiQ_lP3Yil5Ekhf_xBEiUXRj6PUczd2ry1vG8S0ZI7FbQD1Jt7tNqz9R_AwIE32aTU0HsO9qt6BnVOiv3R3cNkohNWfwM_-sm0usMvcEl96Hkp6sUnNcLlx7FdDTA9m602Xjm_ZdNLOJy2JmqIOGWWemHU3UUgMbZgk5CmM97-c9AdxqLoQlwLxR5w6pXHH8rKwQpborNrKa-EK5XXGqyzxTlcF4h5fqDwVqZXeOV8gSPfOu6LIsmewXTd1tQvMor9JBasEZTkSKtFliWrUKsEhUPgyiSBZa9NMV8k1zDWnBG1hyBahVCbawiwi2EWtG3uOS6AZf08p8IoLJcJMHcG7zhQbUXZ2QbS1XJgfxwdGDIbDg5NRavoRvFnbyuBkogiJratmfmlyyraTCRUBu-MJjRgHMWuPR_B8ZeWrLw9jJALemf1_f8kcnR6OcvniToEv4cGKpULMt1ew3c7m1WuEQm2xB1sp_4rt58Mhtd_SvW6w_wXX__8h
link.rule.ids 315,783,787,1378,2228,11574,24330,27936,27937,46064,46306,46488,46730,50826,50935
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgPMALg_GxjI_5AfGWyY1jJ36cOrZsXaoJ2jGJB8uO46qqlKCRSht_PXdJWigaEkK8-aE95ew738_nn-8IeYdF0ZgDB2TCp2FcDCSSANLQ8TKJWWoK1ybc8rHMpvHZlbjq-U_4FqarD7FOuKFntPs1OjgmpDe9XHEVDmQiV5xIGAGefADOz7GNw9HHdSkpQM591U81CKWMWc_16lk9dwnaiFT3vakBv-LU39wFRjexbRucjrfJYqVWx0lZHCwbe1B8_63i4__R-wl53GNYetgZ3VNyr6x2yM4lEmva17007y_sn5Evw9umXsCQHt2CirO-WRidV_RwVjqa1cghoaZaDzExTC_mzXLeoKgLOHjTNm3ZvnFBMRiKUchzMj3-MBlmYd_PISwEIJswcqmCWOilNUIWcAw2pVfC2dQrHpeceadKC4jK2zSJRGSkd85bgP_eeWct5y_IVlVX5S6hBk6y2ApLYP0kkTJVFDwZqJSBcVlfsICw1drpr13ZDv3LcQfmT-P89U04Yf70TUB2YY21mcHmqqefIrzShS0YAKwKyPt24deizPUCCXGJ0J_HJ1pko9HJJI_0MCD7K8vQ4KZ492Kqsl5-0wnW8eEiDQj9wy8UoCdAw4M4IC87m_r55Skox3gUkLi1jL9VSZ9dnuaJ3Pu3v-2Th9kkP9fnp-PRK_KoI8og-e412Wqul-UbQGONfdu62Q86_yP6
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NbxMxELWgSIgLhQLt8lUfELetvB_22scqJU0bEkXQlEocLHu9jkKk3apspLa_npndTSCoSAhx8yEZ7dgz9rP9_IaQdyiKxhwkIONehmkeCSQByNAlRZYyaXLXHLiNxmIwTU8v-EUnKYRvYVp9iPWBG2ZGM19jgl86v5nkKlFhJDKxokRCC-Dkg1QADkZ89GmtJAXAuRP9VFEoRMo6qldH6rnL0MZCdd-bCuAr9vz1XVh0E9o2a1N_m3xbedVSUhYHy9oe5Le_CT7-F7efkMcdgqWHbcg9JfeKcofsnCOtpnnbS0fddf0z8rV3U1cLaNKjG_Bw1pUKo_OSHs4KRwcVMkioKddNPBamk3m9nNdoagLbbtocWjYvXNAMLsRo5DmZ9j-c9QZhV80hzDngmjB2UsFK6IU1XOSwCTaFV9xZ6VWSFgnzThUW8JS3Mot5bIR3zlsA_955Z22SvCBbZVUWe4Qa2MdiISyO6klcMpXnSRYpySC0rM9ZQNhq6PRlK9qhf9nsQP9p7L-uBCf0n74OyB4MsTYzmFr19HOMF7owAQN8VQF534z72pS5WiAdLuP6y_hY88FweHw2inUvIPurwNCQpHjzYsqiWn7XGar4JFwGhP7hFwqwE2DhKA3IbhtSP79cgnMsiQOSNoHxty7p0_OTUSZe_tvf9snDyVFffzwZD1-RRy1LBpl3r8lWfbUs3gAUq-3bJsl-AKGLIqk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytokine+dysregulation+in+aged+horses+and+horses+with+pituitary+pars+intermedia+dysfunction&rft.jtitle=Journal+of+veterinary+internal+medicine&rft.au=McFarlane%2C+D&rft.au=Holbrook%2C+T+C&rft.date=2008-03-01&rft.issn=0891-6640&rft.volume=22&rft.issue=2&rft.spage=436&rft_id=info:doi/10.1111%2Fj.1939-1676.2008.0076.x&rft_id=info%3Apmid%2F18371032&rft.externalDocID=18371032
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0891-6640&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0891-6640&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0891-6640&client=summon